CTOs on the Move

Southwest Community Health Center

www.swhealthcenter.org

 
Southwest Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Santa Rosa, CA. To find more information about Southwest Community Health Center, please visit www.swhealthcenter.org
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

HandsFree Health

WellBe® is a digital health platform that provides voice-activated assistance with health questions, reminders, and entertainment using a smart speaker.

Westside Women's Health Center

Westside Women's Health Center is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Schwabe North America

Schwabe North America is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gillette Children`s Specialty Healthcare

Make a difference—in your life and in the world—with a rewarding career at Gillette Children`s Specialty Healthcare. Gillette is a Twin Cities Top Workplace and a National Top Workplace. We offer competitive pay, a strong benefits package and flexible schedules. Plus we give employees something that sets us apart: a chance to take part in our mission. Come to work for Gillette, and you`ll improve the lives of countless children and adults who have disabilities or complex medical conditions. Each year, we see more patients and add more services. That growth enabled us to increase our workforce by more than 30 percent during the past five years. As we continue expanding, you`ll have many chances to learn new skills and advance your career. You`ll also collaborate with teams of caring professionals who are committed to making the world a better place.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.